CIndU Control in the CURE Registry

Identifying a trigger is only part of understanding chronic inducible urticaria (CIndU). Drawing on findings from the CURE registry, Nicholas Brownstone, MD, examines treatment patterns and disease control among 774 adults with isolated CIndU. Nearly seven in ten patients had poorly controlled disease, including many receiving second-generation H1-antihistamines. Perhaps equally striking, nearly one in five received no treatment at all, most of whom remained poorly controlled. The findings offer a revealing picture of the unmet need in routine care.